Elsevier,
Annals of Hepatology, Volume 27, 1 November 2022
This article aligns with the SDG goal 3 of Good health and wellbeing and SDG 10 Reduced inequalities by highlighting the importance of hepatitis C virus testing among high-risk population groups such as people living with HIV and intravenous drug users.
Elsevier, The Lancet Regional Health - Europe, Volume 22, November 2022
This Article supports SDGs 3 and 10, examining the mortality risk for people aged 25-44 years with disability, and shows that the risk increases with different types and severities of disability and is particiularly associated with mental health problems and motor impairment
Elsevier,
American Journal of Clinical Nutrition, Volume 116, 1 November 2022
The positive association of choline for cognition has been reported in both animal and human studies, yet the associations of choline with the risks of incident dementia or Alzheimer’s disease (AD) in humans is unclear and the objective of this paper was to test the hypothesis that lower or higher dietary choline intake is associated with increased or decreased, respectively, risks of incident dementia and AD. The paper concludes that low dietary choline intake was associated with increased risks of incident dementia and AD and that further investigations regarding the effects of high choline intake on dementia and AD risks are warranted.
The Lancet Neurology, Volume 21, Issue 11, November 2022, Pages 1004-1060,
This update to the 2017 Lancet Neurology Commission on traumatic brain injury advances SDG 3 by presenting new insights and challenges across a range of topics around traumatic brain injury, a leading cause of injury-related death and disability worldwide, with devastating effects on patients and their families.
Elsevier,
SSM - Mental Health, Volume 2, 2022
This article ties to SDG 3. In this article, a system innovation perspective was used to examine the factors influencing the potential for scaling up a task-sharing psychological intervention for refugees called ‘Problem Management Plus’ (PM+) in the Netherlands.
